Amgen Inc. v. Conn. Retirement Plans

Amgen Inc. v. Connecticut Retirement Plans was a legal case where Amgen sued the Connecticut Retirement Plans for allegedly overpaying on drug patents. Amgen claimed that the state fund used an improperly inflated patent valuation to increase royalty payments, which could harm Amgen’s patent rights and financial interests. The court examined whether the valuation method was fair and whether the payments were reasonable. The case highlights issues of patent valuation, licensing agreements, and whether royalty payments are appropriate, emphasizing the importance of accurate patent assessments in licensing arrangements.